Page 66 - 76_02

ANDRÉS R. ALCÁNTARA LEÓN Y COLS. AN. R. ACAD. NAC. FARM.

90. Patel, R. N., et al. (2002) Enantioselective microbial reduction of 2-oxo-2-
91. (1’,2’,3’,4’-tetrahydro-l’,1’,4’,4’-tetramethyl-6’-naphthalenyl)acetic acid and its
92. ethyl ester. Tetrahedron Asymmetry. 13: 349.
93. Langer, S. Z. & l-Hicks, P. E. (1984) Alpha-adrenoceptor subtypes in blood
94. vessels: physiology and pharmacology. J. Cardiovasc. Pharmacol. 6: 547.
95. Manoury, P. M., et al. (1986) Synthesis and antihypertensive activity of
96. a series of 4-amino-6,7-dimethoxy-quinazoline derivatives. J. Med. Chem.
97. 29: 19.
98. Manoury, P. M.; Binet, J. & Cavero, I. (1982) Pyridine derivatives and their
99. use in therapeutic. Eur. Pat. Appl., EP 61379 Al 19820929 CAN 98:89179 AN
100. 1983:89179.
101. Sánchez, V. M.; Rebolledo, F. & Gotor, V. (1997) Candida antarctica lipase
102. catalyzed resolution of ethyl (±)-3-aminobutyrate. Tetrahedron Asymmetry. 8:
103. 37-40.
104. Baldessari, A. & Mangone, C. P. (2001) One-pot biocatalyzed preparation
105. of substituted amides as intermediates of pharmaceuticals. J. Mol. Catal. B:
106. Enzymatic. 11: 335.
Jajoo, H. K., et al. (1989) Metabolism of the antianxiety drug buspirone in
human subjects. Drug Met. Disposition. 17(6): 634.
Mayol, R. F. (2000) Buspirone metaholite for the alleviation of anxiety, Cont.-
in-part of U.S. Ser. No. 484, 161 US 6150365 A 20001121 CAN 133:359250
AN 2000:819478.
Yevich, J. P., et al. (2003) Antianxiety composition using BMY 28674, and
preparation thereof US. Pat. Appl. Publ., Cont.-in-part of U.S. Ser. No. 588,220.
U.S. 2003069251 Al 20030410 CAN 138:281 137 AN 2003:282120.
Yevich, J. P., et al. (2003) S-6-Hydroxy-buspirone for treatment of ansiety,
depression and related disorders. U.S. Pat. App Publ.
Yevich, J. P., et al. (2003) R-6-hydroxybuspirone for the treatment of anxiety,
depression, and other psychogenic disorders. PCT mt. Appl., WO 2003009851
Al 20030206 CAN 138:131155 AN 2003:97305.
Hanson, R. L., et al. (2005) Preparation of (R)- and (S)-hydroxybuspirone
by enzymatic resolution and hydroxylation. Tetrahedron Asymmetry. 16(16):
2711.
Waldmann, H., et al. (1996) Selective enzymic removal of protecting groups:
the phenylacetamide as amino protecting group in phosphopeptide synthe-
sis. Tetrahedron Lett. 37: 8725.
Costello, C. A., et al. (1996) Selective deprotection of phthalyl protected
amines. Tetrahedron Lett. 37: 7469.
Bommarius, A. S., et al. (1997) L-methionine related L-amino acids by acyla-
se cleavage of their corresponding N-acetyl-D,L-derivatives. Tetrahedron
Asymmetry. 8: 3197.
Ogawa, J. & Shimizu, S. (2000) Stereoselective synthesis using hydantoina-
ses and carbamoylases. In Stereoselective Biocatalysis. Patel, R .N., Ed. Mar-
cel Dekker, New York.
Ogawa, J., et al. (1995) Purification and characterization of N-carbamoyl-L-
aminoacid amidohydrolase with broad substrate specificity from Alcaligenes
xylosoxidans. Appl. Microbiol. Biotechnol. 43: 1039.

304